Sanofi expects 2023 business EPS to grow low single digit at CER, barring unforeseen major adverse events. Applying average April 2023 exchange rates, the currency impact on 2023 business EPS is estimated between -5.5% to -6.5%.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on SNY:
- Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Provention
- ALX Oncology enters clinical trial collaboration with Sanofi
- SNY Upcoming Earnings Report: What to Expect?
- Sanofi announces launch of AVAXIM Junior in U.K.
- Sanofi price target raised to EUR 90 from EUR 85 at Deutsche Bank